Regulation and Role of Nuclear Receptor Coactivator AIB1 in Breast Cancer

2003 ◽  
Author(s):  
Kristina J. Lauritsen ◽  
Anna T. Riegel
Keyword(s):  
Breast Cancer ◽  
Nuclear Receptor ◽  
Nuclear Receptor Coactivator

scholarly journals Role of Nuclear Receptor Coactivator 3 (Ncoa3) in Pluripotency Maintenance

2012 ◽  
Vol 287 (45) ◽  
pp. 38295-38304 ◽  
Author(s):  
Zhaoting Wu ◽  
Meng Yang ◽  
Hongjie Liu ◽  
Hongchao Guo ◽  
Yuan Wang ◽  
...  
Keyword(s):  
Nuclear Receptor ◽  
Nuclear Receptor Coactivator ◽  
Pluripotency Maintenance

scholarly journals Recurrent uterine tumors resembling ovarian sex-cord tumors with the growth regulation by estrogen in breast cancer 1-nuclear receptor coactivator 2 fusion gene: a case report and literature review

2020 ◽  
Vol 15 (1) ◽  
Author(s):  
Bin Chang ◽  
Qianming Bai ◽  
Lin Liang ◽  
Huijuan Ge ◽  
Qianlan Yao
Keyword(s):  
Breast Cancer ◽  
Nuclear Receptor ◽  
Growth Regulation ◽  
Fusion Gene ◽  
Nuclear Receptor Coactivator ◽  
Mesenchymal Neoplasms ◽  
Uterine Tumors ◽  
Molecular Events ◽  
Pathologic Features ◽  
Mitotic Figures

Abstract Background Uterine tumors resembling ovarian sex-cord tumors (UTROSCTs) are rare mesenchymal neoplasms predominantly arising in perimenopausal and postmenopausal women. UTROSCTs with growth regulation by estrogen in breast cancer 1 (GREB1)-rearrangement or GREB1-rearranged uterine tumors are exceptionally rare, with only 12 previously reported cases. Here, we report a case of UTROSCT with the GREB1-nuclear receptor coactivator 2 (NCOA2) fusion gene. Case presentation A 57-year-old woman presented with a 10.0 cm uterine mass. The tumor was composed of short spindle or epithelioid cells, arranged in diffused sheets, nested, and trabecular/cordlike. The tumor harbored the GREB1-NCOA2 fusion gene, as confirmed by RNA sequencing. The tumor recurred in the pelvis at 30 months after the initial diagnosis. We also compared the clinical and pathologic features of this case with those of the 12 previously published uterine GREB1-rearranged tumors. Of the combined 13 cases (present case and 12 previous cases), the mean age of patients was 64.8 years (range, 51–74 years). Of the nine reported cases of GREB1-rearranged tumor with follow up, four cases recurred or metastasized (44.4%). Microscopically, most tumors (10/12, 83.3%) showed infiltrative growth, and two were well demarcated. Mitotic figures ranged from 0 to 14 per 10 high-power fields (2 mm2; mean: 3.6). Lymphovascular invasion and necrosis were each present in two cases (2/12, 16.7% and 2/7, 28.6%, respectively). Conclusions This case provided further evidence that UTROSCTs with GREB1-rearrangement may have a high risk of recurrence/metastasis. Further studies are necessary to clarify the clinical features of this type of tumor, particularly the prognosis, potential treatment, and range of possible molecular events.

scholarly journals Overexpression of an N-Terminally Truncated Isoform of the Nuclear Receptor Coactivator Amplified in Breast Cancer 1 Leads to Altered Proliferation of Mammary Epithelial Cells in Transgenic Mice

2005 ◽  
Vol 19 (3) ◽  
pp. 644-656 ◽  
Author(s):  
Maddalena T. Tilli ◽  
Ronald Reiter ◽  
Annabell S. Oh ◽  
Ralf T. Henke ◽  
Kevin McDonnell ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cell Proliferation ◽  
Epithelial Cell ◽  
Transgenic Mice ◽  
Nuclear Receptor ◽  
Mammary Epithelial Cell ◽  
Mammary Epithelial ◽  
Early Gene ◽  
Nuclear Receptor Coactivator ◽  
Igf I

Abstract Amplified in breast cancer 1 (AIB1, also known as ACTR, SRC-3, RAC-3, TRAM-1, p/CIP) is a member of the p160 nuclear receptor coactivator family involved in transcriptional regulation of genes activated through steroid receptors, such as estrogen receptor α (ERα). The AIB1 gene and a more active N-terminally deleted isoform (AIB1-Δ3) are overexpressed in breast cancer. To determine the role of AIB1-Δ3 in breast cancer pathogenesis, we generated transgenic mice with human cytomegalovirus immediate early gene 1 (hCMVIE1) promoter-driven over-expression of human AIB1/ACTR-Δ3 (CMVAIB1/ACTR-Δ3 mice). AIB1/ACTR-Δ3 transgene mRNA expression was confirmed in CMV-AIB1/ACTR-Δ3 mammary glands by in situ hybridization. These mice demonstrated significantly increased mammary epithelial cell proliferation (P < 0.003), cyclin D1 expression (P = 0.002), IGF-I receptor protein expression (P = 0.026), mammary gland mass (P < 0.05), and altered expression of CCAAT/enhancer binding protein isoforms (P = 0.029). At 13 months of age, mammary ductal ectasia was found in CMV-AIB1/ACTR-Δ3 mice, but secondary and tertiary branching patterns were normal. There were no changes in the expression patterns of either ERα or Stat5a, a downstream mediator of prolactin signaling. Serum IGF-I levels were not altered in the transgenic mice. These data indicate that overexpression of the AIB1/ACTR-Δ3 isoform resulted in altered mammary epithelial cell growth. The observed changes in cell proliferation and gene expression are consistent with alterations in growth factor signaling that are thought to contribute to either initiation or progression of breast cancer. These results are consistent with the hypothesis that the N-terminally deleted isoform of AIB1 can play a role in breast cancer development and/or progression.

scholarly journals The Nuclear Receptor Coactivator Amplified in Breast Cancer-1 Is Required for Neu (ErbB2/HER2) Activation, Signaling, and Mammary Tumorigenesis in Mice

2008 ◽  
Vol 68 (10) ◽  
pp. 3697-3706 ◽  
Author(s):  
Mark P. Fereshteh ◽  
Maddalena T. Tilli ◽  
Sung Eun Kim ◽  
Jianming Xu ◽  
Bert W. O'Malley ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Nuclear Receptor ◽  
Mammary Tumorigenesis ◽  
Nuclear Receptor Coactivator ◽  
Activation Signaling
Sign in / Sign up

Export Citation Format

Share Document